Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
This clinical trial update notes a study analyzing primary and metastatic tumors in patients with renal cell carcinoma and urothelial carcin…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Development of AI Model for Renal Tumor Diagnosis Using CT and Lab Tests
A completed clinical trial update from RenJi Hospital describes development of an AI model to diagnose renal tumors using CT imaging and lab…
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Papillary; Chromophobic; Oncocytic) With Mutations in VHL, PBRM1 / BAP1, SETD2, VEGF)
An expanded access program for Axitinib in advanced renal cell carcinoma (including tumors with VHL, PBRM1/BAP1, SETD2 mutations) is no long…
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003) [Phase 2]
Phase 2 clinical trial evaluating belzutifan in combination with cabozantinib for clear cell renal cell carcinoma; the MK-6482-003 study is …
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: A Study of IBI363 in Subjects with Advanced Solid Malignancies [Phase 2]
Phase 2 study of IBI363 in advanced solid malignancies is currently recruiting, with indications including melanoma, non-small cell lung can…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: Fruquintinib and SeRplulimab: Opening New Frontiers in Treating Non-clear Cell Renal Cell Carcinoma [Phase 2]
Phase 2 trial evaluating Fruquintinib plus SeRplulimab for non-clear renal cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: An Exploratory Study on the Failure of Immunotherapy With Voronib Combined With Everolimus [Phase 2]
This entry notes a Phase 2 exploratory trial of Voronib in combination with Everolimus for renal cell carcinoma. The study is currently recr…
-
CLINICAL_TRIALS research · 2024-12-18Clinical Trial Update: Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER) [NA]
The LAYOVER trial evaluating locally ablative therapy for oligoprogressive genitourinary tumors is currently recruiting in prostate cancer, …
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Clinicopathological Features of Renal Cell Carcinoma in Young Patients
Assiut University is planning a clinical study to characterize the clinicopathological features of renal cell carcinoma in young patients, a…
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Zero Ischemia Robot-Assisted MWA Assisted Suture-less Tumor Enucleation of RCC With T1 Stage [NA]
This clinical trial update shows recruitment for a zero-ischemia, robot-assisted microwave ablation with suture-less tumor enucleation for r…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Investigation of Differential Biology of Benign and Malignant Renal Masses Using Advanced Magnetic Resonance Imaging Techniques [NA]
University of Cambridge is conducting a study to differentiate benign from malignant renal masses using advanced magnetic resonance imaging …
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: A Study of 3D Visualization Techniques to Improve the Quality and Safety of Robot-assisted Nephron Sparing Surgery for Complex Renal Tumors. [NA]
This clinical trial registry entry describes a study evaluating 3D visualization techniques to improve the quality and safety of robot-assis…
-
CLINICAL_TRIALS research · 2024-11-25Clinical Trial Update: A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) [Phase 1, Phase 2]
GI Innovation's GI-102 is being studied in a phase 1/2 trial as a single agent and in combination with pembrolizumab or trastuzumab deruxtec…
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: A Study of Belzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018) [Phase 1]
This is a Phase 1 study update of belzutifan (MK-6482) in participants with advanced clear cell renal cell carcinoma. The trial is currently…
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors [Phase 1]
Phase 1 study evaluating XL092 as a single-agent and combination therapy for solid tumors, including renal cell carcinoma, hormone receptor-…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: A CCafU-UroCCR Randomized Trial: 3D Image-Guided Robot-AssisTEd Partial Nephrectomy for Renal Complex Tumor (UroCCR N°99) [NA]
A randomized trial evaluating 3D image-guided robot-assisted partial nephrectomy for renal complex tumors is currently recruiting. No result…
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067 [Phase 1, Phase 2]
Phase 1a/Phase 2 study evaluating safety, preliminary efficacy, PK and PD of ST-067 in various cancers; currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-06Clinical Trial Update: Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell Carcinoma [EARLY_Phase 1]
Clinical trial update announcing recruitment for an early-phase study that rapidly sequences and evaluates approved therapies in patients wi…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer [Phase 2]
A Phase 2 clinical trial update on Cardonilmab for second-line or higher advanced melanoma and advanced renal cancer, focusing on safety and…
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: Comparison of Postoperative Analgesic Efficacy of the Erector Spina Plane Block and Quadratus Lumborum Block in Open Nephrectomy: a Prospective Randomized Clinical Study [NA]
This clinical trial update shows a prospective randomized study comparing erector spinae plane block versus quadratus lumborum block for pos…
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells [EARLY_Phase 1]
Early-phase clinical trial update for Anti-CD70-CAR-T Cell injection targeting CD70+ renal cell carcinoma, currently recruiting.
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy [NA]
A clinical trial update noting recruitment for a study evaluating telemonitoring to manage side effects in patients with melanoma, lung canc…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer [Phase 3]
A Phase 3 trial evaluating TQB2450 plus Anlotinib hydrochloride capsule versus Sunitinib in patients with advanced renal cell carcinoma; the…
-
CLINICAL_TRIALS research · 2024-10-04Clinical Trial Update: Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors.
This clinical trial update describes a study evaluating skin health and quality of life in patients receiving anti-PD-1/PD-L1/CTLA-4 inhibit…
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies [Phase 1, Phase 2]
This clinical trial update describes ongoing Phase 1/2 evaluation of NGM707 as a monotherapy and in combination with pembrolizumab in advanc…